
Neurocrine Biosciences (NBIX) Earnings Dates & Reports
Neurocrine Biosciences (NBIX) Most Recent Earnings
Report DateMay 5, 2025
Period EndingQ1 2025
Est. EPS$1.09
Actual EPS$0.70
EarningsMiss
Neurocrine Biosciences (NBIX) Earnings
View the latest Neurocrine Biosciences (NBIX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Neurocrine Biosciences (NBIX)
Order type
Buy in
Order amount
Est. shares
0 shares
Neurocrine Biosciences (NBIX) Earnings per Share (EPS) History
Signup for full accessBrowse free
Neurocrine Biosciences (NBIX) Latest Earnings
The value each NBIX share was expected to gain vs. the value each share gained.
Neurocrine Biosciences (NBIX) reported its most recent earnings on May 5, 2025 for Q1 2025, posting earnings per share (EPS) of $0.70. This exceeded analysts' expectations of $1.09 by 35.78%, marking a Miss.
For comparison, Neurocrine Biosciences reported EPS of $1.20 in the same quarter last year.
The company is expected to announce its next earnings report on 07/31/2025, with analysts projecting an EPS of $1.50.
Neurocrine Biosciences (NBIX) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2025Jul 31, 2025 | $1.50 | Next earnings call Jul. 31, 2025 | ||
Q1 2025May 5, 2025 | $1.09 | $0.70 | -35.78% | |
Q4 2024Feb 6, 2025 | $1.71 | $1.69 | -1.17% | |
Q3 2024Oct 30, 2024 | $1.51 | $1.81 | +19.87% | |
Q2 2024Aug 1, 2024 | $1.03 | $1.63 | +58.25% | |
Neurocrine Biosciences (NBIX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Neurocrine Biosciences’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 5, 2025 | — | — | — |
Feb 6, 2025 | — | — | — |
Oct 30, 2024 | — | — | — |
Aug 1, 2024 | — | — | — |
Neurocrine Biosciences (NBIX) Earnings FAQs
Neurocrine Biosciences (NBIX) last reported earnings on May 5, 2025 for Q1 2025, posting an EPS of $0.70, which Miss the estimate of $1.09 by 35.78%.
For Q1 2025, Neurocrine Biosciences (NBIX) reported an EPS of $0.70, missing analysts' estimate of $1.09 by 35.78%.
For Q1 2025, Neurocrine Biosciences (NBIX) Miss expectations with an actual EPS of $0.70 vs. an estimated EPS of $1.09.
Following the last earnings report on May 5, 2025, Neurocrine Biosciences (NBIX)'s stock price moved — from — to —.
The next Neurocrine Biosciences (NBIX) earnings call is scheduled for Jul. 31, 2025, where executives will discuss financial results and outlook.